Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| renal alpha-intercalated cell | 7 studies | 61% ± 11% | |
| epithelial cell | 6 studies | 42% ± 27% | |
| fibroblast | 5 studies | 30% ± 20% | |
| dendritic cell | 4 studies | 32% ± 9% | |
| classical monocyte | 3 studies | 18% ± 2% | |
| conventional dendritic cell | 3 studies | 37% ± 14% | |
| plasma cell | 3 studies | 37% ± 20% | |
| endothelial cell | 3 studies | 28% ± 8% | |
| basal cell | 3 studies | 43% ± 17% | |
| kidney distal convoluted tubule epithelial cell | 3 studies | 24% ± 2% |
Insufficient scRNA-seq data for expression of TMEM101 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 1480.80 | 328 / 328 | 100% | 39.98 | 178 / 178 |
| prostate | 100% | 1688.16 | 245 / 245 | 100% | 52.51 | 501 / 502 |
| skin | 100% | 1806.04 | 1809 / 1809 | 100% | 57.98 | 471 / 472 |
| thymus | 100% | 1590.47 | 653 / 653 | 100% | 47.09 | 603 / 605 |
| brain | 100% | 832.38 | 2633 / 2642 | 100% | 33.74 | 705 / 705 |
| liver | 100% | 858.74 | 226 / 226 | 100% | 36.64 | 404 / 406 |
| kidney | 100% | 5290.25 | 89 / 89 | 99% | 61.53 | 896 / 901 |
| intestine | 100% | 1309.89 | 966 / 966 | 99% | 37.15 | 522 / 527 |
| lung | 100% | 1361.75 | 577 / 578 | 99% | 40.58 | 1145 / 1155 |
| stomach | 100% | 1481.22 | 359 / 359 | 99% | 29.69 | 282 / 286 |
| esophagus | 100% | 1311.51 | 1445 / 1445 | 98% | 18.31 | 180 / 183 |
| bladder | 100% | 1411.29 | 21 / 21 | 98% | 44.22 | 492 / 504 |
| adrenal gland | 100% | 1312.97 | 258 / 258 | 97% | 35.79 | 224 / 230 |
| breast | 100% | 2497.79 | 459 / 459 | 95% | 66.35 | 1064 / 1118 |
| ovary | 100% | 1393.84 | 180 / 180 | 89% | 22.48 | 384 / 430 |
| uterus | 100% | 1992.62 | 170 / 170 | 88% | 37.73 | 405 / 459 |
| adipose | 100% | 1151.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 114.18 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 41.77 | 29 / 29 |
| spleen | 100% | 1363.78 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 38.95 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 24.79 | 1 / 1 |
| muscle | 100% | 1287.90 | 802 / 803 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 936.65 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 918.63 | 853 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 93% | 1093.67 | 864 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
| GO_0005575 | Cellular component | cellular_component |
| GO_0016020 | Cellular component | membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | TMEM101 |
| Protein name | Transmembrane protein 101 Transmembrane protein 101 (Putative NF-kappa-B-activating protein 130) |
| Synonyms | |
| Description | FUNCTION: May activate NF-kappa-B signaling pathways. . |
| Accessions | ENST00000585950.5 Q96IK0 K7EPU9 K7EM72 ENST00000589334.5 ENST00000592127.5 ENST00000587529.1 K7ERS4 K7EM07 ENST00000590905.1 ENST00000206380.8 |